CAPPABIANCA, LUCIA ANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.171
EU - Europa 1.820
AS - Asia 1.725
SA - Sud America 251
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 27
OC - Oceania 6
Totale 7.122
Nazione #
US - Stati Uniti d'America 3.108
SG - Singapore 720
CN - Cina 408
RU - Federazione Russa 408
IE - Irlanda 354
IT - Italia 248
BR - Brasile 212
DE - Germania 210
TR - Turchia 171
HK - Hong Kong 164
VN - Vietnam 145
GB - Regno Unito 120
SE - Svezia 103
UA - Ucraina 96
FI - Finlandia 82
FR - Francia 73
CA - Canada 36
IN - India 29
CZ - Repubblica Ceca 26
AT - Austria 17
BD - Bangladesh 17
PL - Polonia 16
MX - Messico 15
NL - Olanda 14
ZA - Sudafrica 14
ES - Italia 13
AR - Argentina 12
BE - Belgio 12
JP - Giappone 11
KR - Corea 10
EC - Ecuador 8
LT - Lituania 7
UY - Uruguay 7
UZ - Uzbekistan 7
IQ - Iraq 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EU - Europa 5
EG - Egitto 4
ID - Indonesia 4
KZ - Kazakistan 4
PH - Filippine 4
BY - Bielorussia 3
CL - Cile 3
CO - Colombia 3
DZ - Algeria 3
PA - Panama 3
PK - Pakistan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
MA - Marocco 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
SA - Arabia Saudita 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GN - Guinea 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TC - Turks e Caicos 1
TH - Thailandia 1
VE - Venezuela 1
Totale 7.005
Città #
Singapore 436
Jacksonville 365
Dublin 353
Chandler 348
San Jose 334
Dallas 269
Ashburn 201
Hong Kong 159
Santa Clara 138
Boardman 124
New York 103
Council Bluffs 93
The Dalles 78
Nanjing 77
Izmir 76
Beijing 71
Wilmington 64
Munich 60
Moscow 55
San Mateo 53
Lawrence 46
Princeton 46
Ann Arbor 41
Dearborn 39
Ho Chi Minh City 39
Lauterbourg 38
Los Angeles 37
Milan 36
L'aquila 35
Hanoi 30
Nanchang 30
Teramo 25
Brno 24
Turku 23
Frankfurt am Main 22
Shenyang 22
São Paulo 22
Rome 21
Dong Ket 20
Helsinki 18
Seattle 17
Verona 17
Orem 16
Tianjin 16
Falls Church 15
Hefei 15
Hebei 14
Toronto 14
Warsaw 14
Mountain View 13
Nuremberg 13
Brooklyn 12
Brussels 12
Columbus 12
Johannesburg 12
L’Aquila 12
Phoenix 12
Woodbridge 12
Boston 11
Chennai 11
Denver 11
Stockholm 11
Tokyo 11
Bremen 10
Montreal 10
Jiaxing 9
Jinan 9
London 9
Shanghai 9
Des Moines 8
Philadelphia 8
Poplar 8
Amsterdam 7
Assisi 7
Ankara 6
Atlanta 6
Auburn Hills 6
Falkenstein 6
Guangzhou 6
Impruneta 6
Kitzingen 6
Kunming 6
Montevideo 6
Rio de Janeiro 6
Salvador 6
Tashkent 6
Vienna 6
Washington 6
West Jordan 6
Biên Hòa 5
Curitiba 5
Da Nang 5
Houston 5
Mexico City 5
Ningbo 5
Norwalk 5
Querétaro 5
Recife 5
San Francisco 5
Acalanes Ridge 4
Totale 4.612
Nome #
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TRKIII in SH-SY5Y cells, unveiling a potential therapeutic “Achilles heel” for the TrkAIII oncoprotein in neuroblastoma 185
Constitutive autotaxin transcription by Nmyc-amplified and non-amplified neuroblastoma cells is regulated by a novel AP-1 and SP-mediated mechanism and abrogated by curcumin 175
NGF sensitizes TrkA SH-SY5Y neuroblastoma cells to TRAIL-induced apoptosis 175
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 164
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation 160
The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma 156
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 155
The enemy from within: Miss-localization of a compromised receptor as a mechanism for TrkAIII oncogenic activity 147
Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es) 145
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer 144
A TaqMan-Based qRT-PCR Assay for Accurate Evaluation of the Oncogenic TrkAIII Splice Variant in Tumor cDNAs 141
The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells 140
All-trans-retinoic acid induces nuclear factor kappa B activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma cells 139
Inhibition of human MDA-MB-231 breast cancer cell invasion by matrix metalloproteinase 3 involves degradation of plasminogen 138
A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target 138
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII 137
TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype. 135
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells 135
Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain. 135
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion 134
Neurotrophin and Neurotrophin Receptor Involvement in Human Neuroblastoma 131
NGF FLIPs TrkA onto the death TRAIL in neuroblastoma cells 128
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells 127
Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in Neuroblastoma 124
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity 122
A Study of Alternative TrkA Splicing Identifies TrkAIII as a Novel Potentially Targetable Participant in PitNET Progression 120
FOLLICLE-STIMULATING HORMONE INCREASES THE EXPRESSION OF TISSUE INHIBITORS OF METALLOPROTEINASES TIMP-1 AND TIMP-2 AND INDUCES TIMP-1 AP-1 SITE BINDING COMPLEX(ES) IN PREPUBERTAL RAT SERTOLI CELLS 117
Alternative TrkA splicing and neuroblastoma 115
TrkAIII expression in the thymus 115
Cis Golgi network-associated TrkAIII targets the interphase centrosome and promotes genetic instability 114
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype. 114
Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma 114
IN VIVO ANALYSIS OF THE MODEL TYROSINE AMINOTRANSFERASE GENE REVEALS MULTIPLE SEQUENTIAL STEPS IN GLUCOCORTICOID RECEPTOR ACTION 113
Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. 112
RETINOIC ACID-ENHANCED INVASION THROUGH RECONSTITUTED BASEMENT MEMBRANE BY HUMAN SK-N-SH NEUROBLASTOMA CELLS INVOLVES MEMBRANE-ASSACIATED TISSUE-TYPE PLASMINOGEN ACTIVATOR 110
TrkAIII: A Novel Hypoxia-regulated Alternative TrkA Splice Variant of Potential Physiological and Pathological Importance 110
TRKAIII COMMUNICATES ER-STRESS TO THE MITO-CHONDRIA IN NEUROBLASTOMA CELLS, RESULTING INGLYCOLYTIC METABOLIC ADAPTATION 110
Mechanisms involved in selecting and maintaining neuroblastoma cancer stem cell populations, and perspectives for therapeutic targeting 110
Reconstitution of TIMP-2 expression in SH-SY5Y neuroblastoma cells by 5-azacytidine is mediated transcriptionally by NF-Y through an inverted CCAAT site 109
Nature of the accessible chromatin at a glucocorticoid-responsive enhancer 108
Thioredoxin inhibits microvascular endothelial capillary tubule formation 107
Molecular Characterization and Inhibition of a Novel Stress-Induced Mitochondrial Protecting Role for Misfolded TrkAIII in Human SH-SY5Y Neuroblastoma Cells 106
Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival 106
POSITIVE AND NEGATIVE REGULATION OF THE COMPOSITE OCTAMER MOTIF OF THE INTERLEUKIN 2 ENHANCER BY AP-1, OCT-2, AND RETINOIC ACID RECEPTOR 105
Nutraceutical Preventative and Therapeutic Potential in Neuroblastoma: From Pregnancy to Early Childhood 104
Alternative TrkA splicing and Cancer 104
The alternative TRKAIII splice variant targets the centrosome and promotes genetic instability 103
Alternative TrkAIII splicing and Cancer 98
The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced Death of SH-SY5Y Neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, whitin the context of a tumour stem cell-like phenotype 96
The TrkAIII splice variant oncoprotein enhances PD-L1 expression in human SH-SY5Y neuroblastoma cells 93
Hypoxia-induced alternative TrkA splicing and reoxygenation-dependent TrkAIII activation: A cycling hypoxia-regulated resistance mechanism in neuroblastoma. 93
A TAQMAN-BASED QRT-PCR ASSAY FOR DETECTING TRKAIII EXPRESSION IN TUMOR TISSUE RNAS 92
Studies on potentially druggable pathways that regulate stress-induced TrkAIII mitochondrial internalization, cleavage and activation in human neuroblastoma cells 92
The Alternative TrkAIII splice variant by neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 90
Genomic footprinting using nucleases 87
The alternative TrkAIII splice variant expressed by human neuroblastomas and glioblastomas targets the centrosome and promotes genetic instability 83
NGF sensitizes TrKA expressing SH-SY5Y nuroblastoma cells to TRAIL-induced apoptosisi 77
TRKAIII PROMOTES PD-L1 EXPRESSION IN SH-SY5Y NEUROBLASTOMA CELLS 71
NGF Sensitizes TrkA SH-SY5Y Neuroblastoma Cells to TRAIL-Induced Apoptosis 51
Jurkat T-Cell Antigen-Independent Elimination of PMA-Activated Neuroblastoma Cells Is Triggered by CCL2/CCR2, Depends Upon Lipid Raft LFA1/ICAM1 Immune Synapses, Is Mediated by m-TRAIL and Is Augmented by the TrkAIII Oncoprotein 40
Alternative Splicing of the NF-Y Subunit, NF-YA, in Neuroblastoma Phenotype Heterogeneity 12
Alternative Splicing in Human Viral Oncogenesis and Tumor Progression 6
null 5
Totale 7.122
Categoria #
all - tutte 29.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022272 0 22 35 14 17 9 9 20 15 8 24 99
2022/2023993 61 70 20 115 91 102 3 44 440 3 23 21
2023/2024284 34 11 25 25 13 89 1 3 5 10 7 61
2024/20251.288 39 17 103 69 154 111 198 97 224 85 100 91
2025/20262.550 115 240 207 344 287 165 366 69 226 349 130 52
2026/2027156 88 68 0 0 0 0 0 0 0 0 0 0
Totale 7.122